Healthy Adult Subjects Clinical Trial
Official title:
Open-Label, Single-Center, Single Dose Positron Emission Topography (PET) Using [11C]PBR28 to Evaluate Brain Translocator Protein 18KDa (TSPO) Occupancy of ONO-2952 in Healthy Adult Subjects
The primary objective of this study is to evaluate the brain TSPO occupancy of ONO-2952 in healthy adult subjects after a single dose using [11C]PBR28 as a specific PET ligand for TSPO. The secondary objective is to evaluate the relationship between TSPO occupancy and the plasma concentration of ONO-2952 and to investigate the safety and tolerability of ONO-2952 in healthy subjects.
n/a
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03267732 -
A Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegilodecakin (LY3500518)
|
Phase 1 | |
Completed |
NCT05040113 -
A Study On Human Mass Balance And Biotransformation
|
Phase 1 | |
Completed |
NCT01433835 -
Safety and Pharmacokinetics of Single Oral Doses of MBX-400 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04029090 -
A Study to Evaluate the Effect of MCI-186 at Therapeutic and Supra-Therapeutic Doses on the QT Interval(QT)/Corrected QT Interval(QTc) Interval in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04586985 -
Safety, Tolerability and Pharmacokinetics of FTX-6058
|
Phase 1 | |
Completed |
NCT04481789 -
Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary Regimen-Finding Study)
|
Phase 1 | |
Completed |
NCT06107205 -
Bioequivalence of TTYP01 Tablets in Healthy Adult Subjects
|
Phase 1 | |
Completed |
NCT04629131 -
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TNM002 in Healthy Adults
|
Phase 1 | |
Recruiting |
NCT06063291 -
Single Ascending Oral Dose Phase 1 Study of ID110521156 in Healthy Adult Subjects
|
Phase 1 | |
Completed |
NCT04203862 -
A Study of NPC-22 in Healthy Adult Males
|
Phase 1 | |
Recruiting |
NCT05641181 -
A Trial of CRB4101 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04521192 -
Bioequivalence of Fluzoparib(SHR3162) Study on Healthy Chinese Adult Subjects
|
Phase 1 | |
Completed |
NCT04400123 -
A Bioequivalence Study of Famitinib Malate on Healthy Chinese Volunteers
|
Phase 1 | |
Completed |
NCT04811469 -
Safety, Tolerability and Pharmacokinetics of CBP-174 in Healthy Adults
|
Phase 1 | |
Completed |
NCT04291846 -
A Food Effect Study of SHR1459 on Healthy Chinese Adult Subjects
|
Phase 1 | |
Completed |
NCT01364441 -
Single-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult Subjects
|
Phase 1 | |
Completed |
NCT02691702 -
Multiple Dose Study Of BIIB118 (PF-05251749) In Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT05334043 -
Pharmacokinetics and Bioavailability of Curcumin UP 30 Capsules in Healthy Adult Subjects
|
Phase 1 | |
Completed |
NCT04493281 -
Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects
|
Phase 1 | |
Completed |
NCT01376063 -
Study to Investigate the Interaction Between FG-4592 and Rosiglitazone in Healthy Adult Subjects
|
Phase 1 |